SOLANA BEACH, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) announced that the United Kingdom’s Home…
REDWOOD CITY, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated…
American Journal of Nephrology data demonstrates KidneyIntelX successfully monitors patient response to SGLT2 therapy in 1,325 CANagliflozin CardioVAScular Assessment Study…
Enrollment complete in INTERGRIS-IPF Phase 2a clinical trial with top-line data expected mid-2022 FDA has authorized evaluation of long-term treatment…
Company on track to report three-month interim study results, including visual acuity, visual sensitivity, mobility and safety data, in Q2…
Forbes Technology Council, Invitation-Only Community for World-Class Technology Executives, Welcomes Dr. Saltman of Eko Eko Chief Medical Officer Dr. Adam…
Yumanity achieves research milestone in its collaboration with Merck; Yumanity to receive $5 million milestone payment Michael J. Fox Foundation…
Dana Brown and Timothy Norris Irish offer extensive experience in technology, women’s breast health and unique global perspectivesNASHUA, N.H., Jan.…
OREM, Utah, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of diverse products and services…
+PlusCBD™ expands product offerings to include four new topicals that provide targeted pain relief +PlusCBD™ Pain Relief topicals +PlusCBD™ Pain…